2BB score and signals
Edgewise Therapeutics, Inc.’s current 2BB score is 42 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 70 | High |
| Momentum | 67 | Improving |
| Financial strength | 28 | Weak |
| Quality | 98 | Very Strong |
| Risk | 36 | Low |
Company facts
| Headquarters | Boulder, Colorado, United States |
| Founded | 2017 |
| Employees | 127 |
| 52-week range | $14.68 – $48.50 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-24 | — | -0.4896 | — | $0.00 |
| 2026-11-05 | — | 3.4706 | — | $0.00 |
| 2026-08-06 | — | -0.4794 | — | $0.00 |
| 2026-05-07 | -0.46 | -0.4964 | $0.00 | $0.00 |
Related companies
